John Philip Jones - 31 Oct 2022 Form 4 Insider Report for ALIMERA SCIENCES INC

Reporting relationship: Chief Financial Officer
Issuer ticker: N/A
Reported as of: 31 Oct 2022
Net transaction value: +$1,651
SEC form: 4
Accepted by SEC: 02 Nov 2022, 17:16:42 UTC
Prior SEC filing: 03 May 2022
Source filing: View source filing
Reporting owner signature: /s/ John Philip Jones

Key filing fact

John Philip Jones filed Form 4 for ALIMERA SCIENCES INC on 02 Nov 2022.

Key facts

This page summarizes John Philip Jones's Form 4 filing for ALIMERA SCIENCES INC.
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 02 Nov 2022, 17:16.

Change

Previous filing in this sequence was filed on 03 May 2022.
Current net transaction value: +$1,651.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALIM transaction

Common Stock

Award

Transaction value: $1,651
Shares: +372
Change %: +1.2%
Price: $4.44
Shares after: 32,185
Date: 31 Oct 2022
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

These shares were acquired under the Alimera Sciences, Inc. 2010 Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(c) and Rule 16b-3(d).